Low FBXW7 expression is associated with decreased chemotherapeutic sensitivity, like taxol and cisplatin in NSCLC (Yokobori et al., 2014; Yu et al., 2013). The gene discussed is FBXW7; the disease is non-small cell lung carcinoma.